HONG KONG: Hong Kong suspended COVID-19 vaccinations from a single batch of Pfizer-BioNTech shots over defective packaging, the South China Morning Post reported on Wednesday (Mar 24), citing sources.
On Wednesday, several centres around the Asian financial hub were told to stop using the Pfizer-BioNTech vaccine, according to notices seen by residents.
The government did not immediately respond to requests for comment.
Health authorities in Macau on Wednesday also said they are suspending the use of Pfizer-BioNTech’s vaccine after being informed of a packaging problem with a batch of vials.
The defects were found in the caps of some vials, said Macau’s government.
“Vaccinations with the concerned products must be suspended,” it said in a statement.
BioNTech and Fosun Pharma, which is the distributor of the vaccines for the Greater China region, have no reason to believe there is a product-safety risk, Macau’s government said.
BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram